Cas:59301-25-6 5-(2-Bromophenyl)-1H-1,2,4-triazol-3-amine manufacturer & supplier

Chemical Name:5-(2-Bromophenyl)-1H-1,2,4-triazol-3-amine

CAS.NO:59301-25-6

Synonyms:5-(2-bromo-phenyl)-1H-[1,2,4]triazol-3-ylamine;3-Amino-5-o-bromphenyl-1,2,4-triazol;5(3)-(2-Bromphenyl)-3(5)amino-1,2,4-triazol;3-(2-bromophenyl)-1H-1,2,4-triazole-5-ylamine;5-(2-bromophenyl)-4H-1,2,4-triazol-3-amine

Molecular Formula:C₈H₇BrN₄

Molecular Weight:239.07200

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:467.3ºC at 760 mmHg

Density:1.732

Index of Refraction:1.701

PSA:68.32000

Exact Mass:237.98500

LogP:1.74650

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-(2-bromo-phenyl)-1H-[1,2,4]triazol-3-ylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(2-bromophenyl)-4H-1,2,4-triazol-3-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(2-bromophenyl)-1H-1,2,4-triazole-5-ylamine Use and application,5-(2-bromophenyl)-4H-1,2,4-triazol-3-amine technical grade,usp/ep/jp grade.

Related News: He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China. 5-(2-Bromophenyl)-1H-1,2,4-triazol-3-amine manufacturer The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). 5-(2-Bromophenyl)-1H-1,2,4-triazol-3-amine supplier He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China. 5-(2-Bromophenyl)-1H-1,2,4-triazol-3-amine vendor Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management, Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said. 5-(2-Bromophenyl)-1H-1,2,4-triazol-3-amine factory Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.